COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia - Wikidata - wikimedia - TriplyDB

COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia

COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia

http://www.wikidata.org/entity/Q24653404

about

Are we causing the recurrence-impact of perioperative period on long-term cancer prognosis: Review of current evidence and practice Morphine for the treatment of pain in sickle cell disease Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome: a retrospective study in patients with advanced prostate cancer Opioids: Modulators of angiogenesis in wound healing and cancer.Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancer.Effect of opiates, anesthetic techniques, and other perioperative factors on surgical cancer patients.Evolution of the Bifunctional Lead μ Agonist / δ Antagonist Containing the Dmt-Tic Opioid Pharmacophore Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer.Morphine-induced early delays in wound closure: involvement of sensory neuropeptides and modification of neurokinin receptor expression.Segmental thoracic spinal has advantages over general anesthesia for breast cancer surgery.Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation.A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection.Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.Morphine use in cancer surgery Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression Influence of morphine on pericyte-endothelial interaction: implications for antiangiogenic therapy Ku80 cooperates with CBP to promote COX-2 expression and tumor growth.Cancer Recurrence and Regional Anesthesia: The Theories, the Data, and the Future in Outcomes.μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancer Does Opioid Use Cause Angiogenesis and Metastasis?Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy The evolution and practice of acute pain medicine Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study.Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.Morphine decreases the pro-angiogenic interaction between breast cancer cells and macrophages in vitro Morphine stimulates platelet-derived growth factor receptor-β signalling in mesangial cells in vitro and transgenic sickle mouse kidney in vivo.Metformin reduces morphine tolerance by inhibiting microglial-mediated neuroinflammation Common mechanisms of pain and depression: are antidepressants also analgesics?Anesthesia, microcirculation, and wound repair in aging.The role of morphine in regulation of cancer cell growth.Patient optimization for gastrointestinal cancer surgery.Impact of anesthesia for cancer surgery: Continuing professional development.Role of cyclooxygenase-2 in gastric cancer development and progression.Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis Chronic opioid therapy in long-term cancer survivors.A systematic review of the impact of pain on overall survival in patients with cancer.Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients.Opioid-induced regulation of mu-opioid receptor gene expression in the MCF-7 breast cancer cell line.

P2860

Q26865763-2B00595F-25BB-4C6C-8EF8-FCA16E89C22A Q28087296-7984550B-C328-4E4A-831E-3C97EF5F0CB5 Q28535425-DF39B333-072C-4E5B-9D58-B5A1418056BB Q33649031-5C3E73D6-4D79-4C27-BC89-45677130471C Q33713908-88BE43A7-4505-4D16-9D44-E5F883650686 Q33737523-05D08690-580A-4781-AEE0-24D50D595F78 Q33747010-6D0110DF-F163-4480-B7BF-9500E49C88C5 Q33951506-33A053BE-AD25-4D27-A3CB-D037C893785B Q34155240-5708446E-EB65-4762-91CD-FBD4E010FF73 Q34236948-DF9B20A9-8BFC-4BBB-AEA7-2D99B5EF2432 Q34382523-C6BE5326-9F7A-47E2-8F9E-FBD167698919 Q35000444-BC9DDE52-C726-4227-91F8-A069C8B866AC Q35011905-4E673F6F-A5D2-4FB5-82C7-F3F77856592B Q35151843-24B7EFCF-931C-40EB-A931-4A124C546C2B Q35612450-6FAF0145-DD62-4901-B238-6B4C24508EA8 Q35725355-AC339097-97B9-4791-B332-DE6CEE7B12FC Q35781503-E12BD091-CE14-4BB3-8462-27E614929F4B Q35800595-4B395D0E-2270-4978-936C-47450A10C708 Q35846683-985CDB38-9CDF-41C5-BDC3-DEAFFDCEA5FC Q35985440-AB588EA3-3D22-4BE4-A0DF-8C7D0EBDF777 Q36062073-B114581E-3DD6-4140-9219-D6BB2DE33F25 Q36324618-BFC41718-47C9-4931-BFFC-E5019C99CB96 Q36539723-6E46D6AB-16A1-460A-8B9D-A08B9200D1E3 Q36594073-90E0D80F-3D82-40DB-A42D-9C78B0E2CBBA Q36773109-47237582-FCDB-4D93-9D7B-27923259E084 Q37051227-D445312F-4BFA-4528-B82B-AA8716721EB2 Q37168985-78F47B85-80E3-4BB6-814B-C5A02E3EE513 Q37308492-1CD11A4C-214C-410A-8319-9961759462FC Q37422131-6A2F78D9-88C2-4512-9385-DA0F12D1C2F1 Q37676446-BB3C8477-E0F5-4E19-B669-5965EF21632E Q37697099-91826202-26A3-46D4-AFBE-718D7598C857 Q37907914-3E953AF2-CAC5-4FBB-9F23-D1ECB6693376 Q38061009-24D73CA8-F05E-4D75-BCD8-82D29FE28AF4 Q38156029-3C5BC163-DC92-43A8-97F1-10DAA554C064 Q38164703-9458D7BD-A570-4808-9EAE-5083F7CFD2C8 Q38182143-224754D9-CF53-4ECA-BCC3-2175EDDBB863 Q38904553-73316F74-E124-48BC-A70E-0A3F2F934A67 Q39132056-77EA8D9A-3B02-4285-A93B-04D8F15A3A02 Q39455513-EB3E3D2F-1FD4-401D-A3B8-FE57A4E9D0A4 Q39975543-D9D5D403-39EC-4B42-A5D5-5B71CE522F23

P2860

COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia

http://www.wikidata.org/entity/Q24653404

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

COX-2 inhibitor celecoxib prev ...... without compromising analgesia

@ast

COX-2 inhibitor celecoxib prev ...... without compromising analgesia

@en

COX-2 inhibitor celecoxib prev ...... without compromising analgesia

@nl

type

label

COX-2 inhibitor celecoxib prev ...... without compromising analgesia

@ast

COX-2 inhibitor celecoxib prev ...... without compromising analgesia

@en

COX-2 inhibitor celecoxib prev ...... without compromising analgesia

@nl

prefLabel

COX-2 inhibitor celecoxib prev ...... without compromising analgesia

@ast

COX-2 inhibitor celecoxib prev ...... without compromising analgesia

@en

COX-2 inhibitor celecoxib prev ...... without compromising analgesia

@nl

P1433

Q24653404-285576BF-8456-40D3-8514-B7711F146645

P1476

Q24653404-027F08CB-185A-4993-8CFD-6785E2BF626D

P2093

Q24653404-24A425F0-E08A-4A8C-9277-A40FE08C7685

Q24653404-6751FC94-6537-4D11-A7A9-7C22581E9D8C

Q24653404-8A20F135-C12C-4CBF-BA95-D45A283960F2

Q24653404-C5234CF1-1211-4B12-90C2-A7C3B7CF4E4F

Q24653404-D05ABC13-BA2A-48D7-8011-5DF019FE8B25

Q24653404-DA6B2B22-F021-4FA9-B95F-A73AE2630E58

Q24653404-E9ECEFF5-CFE2-4495-88AD-4816797072B8

P2860

Q24653404-007E88AE-DD80-4063-B8FB-610E0EE54CDE

Q24653404-011F18DF-0533-4238-9410-54B19CE60AA3

Q24653404-028AAEB6-D59F-48BA-A33B-AAE24DDE7CE9

Q24653404-06F75B5B-8498-4A09-9041-D997D77BE6C3

Q24653404-076F1309-8D6A-462B-B6A9-5A9555545474

Q24653404-0B053AB7-AB38-43E3-9C59-D552CB17EB5C

Q24653404-1BEE991F-2E7B-4BF0-931A-F8C3F0334A02

Q24653404-1D9D59A9-6EED-4725-A1EC-8A6AAAF03E64

Q24653404-276C9B7E-BA94-438C-8391-42DC2BAB6FAA

Q24653404-2C7F2A32-23C1-4B78-A185-38376EA42FA4

P2888

Q24653404-5A20C126-73A6-4118-9293-136A1010BD7D

P304

Q24653404-666F14BD-D24A-4B90-AE77-6B6D7E12BE74

P31

Q24653404-C5315388-0408-4149-9513-90D7CF768EF4

P3181

Q24653404-626C8AEE-52DA-49FF-8408-320D2041545A

P356

Q24653404-642C0904-45A2-4787-8335-E982B14ADCBB

P407

Q24653404-9D9C6541-EB69-4D8A-8836-A530835E530F

P433

Q24653404-EDA5D0B4-C7F1-48C9-B390-62321A8D65D8

P478

Q24653404-3D3C59E9-E731-45B6-880C-CA6A62586F65

P577

Q24653404-62FA71F7-A254-4CDD-B888-D566A25BF7E9

P5875

Q24653404-AB56E627-EAA7-48CA-9E91-7A5F1A7B1AD2

P6179

Q24653404-D6DB6954-2673-476C-AE70-A19ED03274F9

P698

Q24653404-41E530D4-749A-4C30-A5D3-76A088DC1148

P932

Q24653404-CD30E36B-6DD5-41E0-95D2-6550FD03F854

P3181

P356

P1433

British Journal of Cancer

P1476

COX-2 inhibitor celecoxib prev ...... without compromising analgesia

@en

P2093

C W Song

http://www.w3.org/2001/XMLSchema#string

K Gupta

http://www.w3.org/2001/XMLSchema#string

M Farooqui

http://www.w3.org/2001/XMLSchema#string

R J Griffin

http://www.w3.org/2001/XMLSchema#string

T Poonawala

http://www.w3.org/2001/XMLSchema#string

T Rogers

http://www.w3.org/2001/XMLSchema#string

Y Li

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular mechanisms of nociception

The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity.

Effects of anti-inflammatory biflavonoid, ginkgetin, on chronic skin inflammation.

Celecoxib: a specific COX-2 inhibitor with anticancer properties.

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

Nitric oxide activates cyclooxygenase enzymes.

Cancer pain and its impact on diagnosis, survival and quality of life.

G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation.

P2888

P304

1523-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4147606

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.BJC.6604057

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5874109

http://www.w3.org/2001/XMLSchema#string

P6179

1020435638

http://www.w3.org/2001/XMLSchema#string

P698

17971769

http://www.w3.org/2001/XMLSchema#string

P932

2360252

http://www.w3.org/2001/XMLSchema#string